SCHEMBL1646897

SCHEMBL1646897

CN(C)c1ccc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2Br)c(Cl)c1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.73
APP P05067 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1646898 1.00 BACE1 (0.73) BACE1APP
SCHEMBL1647249 0.86 BACE1 (0.80) BACE1
SCHEMBL1647252 0.86 BACE1 (0.80) BACE1
SCHEMBL1647373 0.84 BACE1 (1.00) BACE1
SCHEMBL1647372 0.84 BACE1 (1.00) BACE1
SCHEMBL1648152 0.83 BACE1 (0.72) BACE1APP
SCHEMBL1648154 0.83 BACE1 (0.72) BACE1APP
SCHEMBL1647148 0.81 BACE1 (0.85) BACE1APP
SCHEMBL1647145 0.81 BACE1 (0.85) BACE1APP
SCHEMBL1645753 0.79 BACE1 (1.00) BACE1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed